The Clinical Research Program at the Cardiovascular Institute allows our physicians to participate in national studies which provide current data to enhance treatment protocols for cardiovascular issues.

Of course, we could not participate without our patients who volunteer to be a part of a clinical trial or registry. Through our participation, select patients may have access to new technologies or medical therapies that are not yet widely available. However, many studies are simply observational and collect data on how patients respond to various therapies that are already the standard of care, to determine where improvements may be needed.  No matter what type of research, it is our patients participation that provides the necessary data to make improvements in cardiovascular treatment.


The selection criteria for each study are very specific.

Most patients will not be asked to participate in research.  Patients who are considered a good candidate for a certain study, and are approached about participating, are under no obligation to enroll.  Your cardiologist and our research coordinator will provide you with comprehensive information to make an informed decision on your study participation and treatment options.  Patients who participate in studies are monitored, most commonly through follow-up appointments, for a prescribed amount of time per the study requirements.  Patients are asked to please consider their long term commitment to attend all follow-up appointments as part of their participation.  While patients can certainly choose to remove themselves from a study, it is our hope that those who choose to enroll will work with us to complete their participation.

At Cardiovascular Institute, we believe that our participation in clinical research gives us access to new data and information that continually improves the quality of care we provide to all of our patients.  We’re proud to bring this level of commitment to treating cardiovascular disease to our community.

If  you have any questions regarding your eligibility for studies that Cardiovascular Institute is currently participating in you may contact our study coordinator:

Marcy McElhaney, at (850)769-0329.


Links to trials actively enrolling at Cardiovascular Institute of Northwest Florida



In addition, to view a short video explanation of the objectives of this trial and to learn who may be a candidate visit

Principal Investigator:  Amir Haghighat, M.D.


AdaptResponse Clinical Trial


A Post Market Observational Study to Obtain Additional Information on the Use of Cormatrix® Cangaroo ECM® Envelope


CHAMP-HF, Change the Management of Patients with Heart Failure, is an observational study.  The study will look at the treatment of heart failure and reasons for changes in treatment and will include those who have been diagnosed with heart failure with reduced ejection fraction.

Principal Investigator:  Michael Morrow, M.D.



Links to trials Cardiovascular Institute continues to monitor



A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System


Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study

Principal Investigator:  Michael Morrow, M.D.


A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.